搜索页_+Bivalent+rLP2086

读者指南

远程访问

科技查新

公务邮箱

NSTL服务站

外文资源

内部出版物

SpringerLink电子期刊(2)

Elsevier电子期刊(6)

在“Elsevier电子期刊”中，命中：6条，耗时：小于0.01 秒

在所有数据库中总计命中：8条

1.Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial

作者：Dr Helen S Marshall ; MD^a ; ^{helen.marshall@adelaide.edu.au} ; Peter C Richmond ; MBBS^b ; Johannes Beeslaar ; MD^c ; Qin Jiang ; MS^d ; Kathrin U Jansen ; PhD^e ; Maria Garcé ; s-Sá ; nchez ; PhD^f ; Federico Martinó ; n-Torres ; PhD^g ; Leszek Szenborn ; MD^h ; Prof Jacek Wysocki ; MDⁱ ; Joseph Eiden ; MD^d ; Shannon L Harris ; PhD^e ; Thomas R Jones ; PhD^e ; Su-San Lee ; BSc^a ; John L Perez ; MD^d ; on behalf of the 6108A12001 Study Investigators^&dagger ;

刊名：The Lancet Infectious Diseases

出版年：2017

2.Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers

作者：David M. Reiner^a ; ^{David.reiner@bayer.com" class="auth_mail" title="E-mail the corresponding author} ; Prakash Bhuyan^b ; ^{Prakash.Bhuyan@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Joseph J. Eiden^c ; ^{joseph.eiden@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; John Ginis^b ; ^{john.ginis@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Shannon Harris^c ; ^{Shannon.Harris@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Kathrin U. Jansen^c ; ^{kathrin.jansen@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Qin Jiang^b ; ^{qin.jiang@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Thomas R. Jones^c ; ^{thomas.r.jones@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Robert E. O&rsquo ; Neill^c ; ^{robert.oneill@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Laura J. York^d ; ^{laura.york@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; John L. Perez^b ; ^{john.perez@pfizer.com" class="auth_mail" title="E-mail the corresponding author}

关键词：Neisseria meningitidis ; Serogroup B ; Vaccine ; Meningococcal disease ; Bivalent rLP2086 ; Laboratory worker

刊名：Vaccine

出版年：2016

3.A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults

作者：Lars Ostergaard^a ; ^{larsoest@rm.dk" class="auth_mail" title="E-mail the corresponding author} ; Gregg H. Lucksinger^b ; ^{glucksinger@tektonresearch.com" class="auth_mail" title="E-mail the corresponding author} ; Judith Absalon^c ; ^{Judith.Absalon@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Johannes Beeslaar^d ; ^{johannes.beeslaar@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Joseph Eiden^c ; ^{joseph.eiden@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Kathrin U. Jansen^c ; ^{kathrin.jansen@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Laura J. York^e ; ^{laura.york@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Angela Quinn^c ; ^{angela.quinn@pfizer.com" class="auth_mail" title="E-mail the corresponding author} ; Mette E. Graversen^a ; ^{metgrave@rm.dk" class="auth_mail" title="E-mail the corresponding author} ; John L. Perez^f ; ^{john.perez@pfizer.com" class="auth_mail" title="E-mail the corresponding author}

关键词：AE ; adverse event ; fHBP ; factor H binding protein ; HAV ; hepatitis A virus vaccine ; IMD ; invasive meningococcal disease ; MAE ; medically-attended adverse event ; MnB ; Neisseria meningitidis serogroup B ; NDCMC ; newly-diagnosed chronic medical condition ; SAE ; serious adverse event

刊名：Vaccine

出版年：2016

4.A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

作者：Helen S. Marshall^a ; ^{Helen.marshall@adelaide.edu.au} ; Peter C. Richmond^b ; ^{peter.richmond@uwa.edu.au} ; Michael D. Nissen^c ; ^{theniss@uq.edu.au} ; Ann Wouters^d ; ^{Ann.Wouters@pfizer.com} ; James Baber^e ; ^{James.Baber@pfizer.com} ; Qin Jiang^d ; ^{Qin.Jiang@pfizer.com} ; Annaliesa S. Anderson^d ; ^{Annaliesa.Anderson@pfizer.com} ; Thomas R. Jones^d ; ^{Thomas.r.jones@pfizer.com} ; Shannon L. Harris^d ; ^{shannon.harris@pfizer.com} ; Kathrin U. Jansen^d ; ^{kathrin.jansen@pfizer.com} ; John L. Perez^d ; ^{John.Perez@pfizer.com}

关键词：(AEs) ; adverse events ; (fHBP also known as rLP2086) ; factor H-binding protein ; (GMT) ; geometric mean titre ; (hSBA) ; human serum bactericidal assay ; (IMD) ; invasive meningococcal disease ; (Mn) ; meningococcal ; (MnB) ; meningococcal serogroup B ; (MnC) ; mening

刊名：Vaccine

出版年：2013

5.Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis

作者：Duzhang Zhu ; Vicki Barniak ; Ying Zhang ; Bruce Green and Gary Zlotnick

关键词：Neisseria meningitidis ; Mouse model ; Adjuvant ; Vaccine

刊名：Vaccine

出版年：2006

6.Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B

作者：Pillai ; Subramonia ; Howell ; Alan ; Alexander ; Kristin ; Bentley ; B. Erin ; Jiang ; Han-Qian ; Ambrose ; Karita ; et. al.

关键词：Neisseria meningitidis ; LP2086 ; OMP ; Vaccine

刊名：Vaccine

出版年：2005

1

按检索点细分(6)

题名(4)

关键词(2)

文摘(6)

按出版年细分(6)

2017年(1)

2016年(2)

2013年(1)

2006年(1)

2005年(1)

网站地图　|　常见问题　|　交通位置　|　联系我们　|　OA远程办公　|　English

© 2004-2018 中国地质图书馆版权所有京ICP备05064691号京公网安备11010802017129号

地址：北京市海淀区学院路29号邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700